Toshiro Hasegawa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(Bloomberg) Daiichi Sankyo Co. shares jumped by the most in a year after a drug it developed with AstraZeneca Plc showed favorable results in a trial for a common type of breast cancer.Most Read from BloombergChinese Gold Buying Is Driving a Paradigm Shift in BullionIndia-Canada Clash Should Be a Wakeup CallWells Fargo Preps for Wealth Battle After $1 Billion TurnaroundIndians Have Five Days to Deposit $3 Billion in Soon-to-Be-Withdrawn BanknotesCorzine Plans to Shut Hedge Fund and Return Cap

Hajime sakaiStephen barkerDaiichi sankyoHidemaru yamaguchiBloomberg businessweekToshiro hasegawaMito securities coJefferies japan ltdAstellas pharma incAstrazeneca plcBloomberg daiichi sankyo coMito securitiesDaiichi breast cancer drug showsCitigroup global marketsAstrazeneca plcBreast cancer